Publications in major medical journals like The New England Journal of Medicine, The Lancet

FDA Approves Cresilon's Traumagel for Rapid Bleeding Control

Aug 15, 2024, 02:15 PM

The U.S. Food and Drug Administration (FDA) has approved Cresilon's Traumagel, an innovative algae-derived gel designed to quickly control life-threatening bleeding from injuries such as stab wounds and gunshot wounds. This new treatment can stop severe bleeding in seconds, offering a significant advantage over current methods that require pressure and take minutes to be effective. The approval marks a significant advancement in emergency medical treatment, providing a rapid and efficient solution for managing critical injuries.